Stock Analysis

Top Growth Companies With High Insider Ownership On KRX

KOSE:A298040
Source: Shutterstock

Over the last 7 days, the South Korean market has dropped 5.7%, driven by declines in every sector, and it is also down 3.9% over the past year. However, with earnings expected to grow by 29% per annum over the next few years, identifying growth companies with high insider ownership could be particularly advantageous in navigating these market conditions.

Top 10 Growth Companies With High Insider Ownership In South Korea

NameInsider OwnershipEarnings Growth
People & Technology (KOSDAQ:A137400)16.5%35.6%
Seojin SystemLtd (KOSDAQ:A178320)30.5%52.1%
Bioneer (KOSDAQ:A064550)17.5%97.6%
Park Systems (KOSDAQ:A140860)33%35.7%
Oscotec (KOSDAQ:A039200)26.3%122%
ALTEOGEN (KOSDAQ:A196170)26.6%99.5%
Vuno (KOSDAQ:A338220)19.5%110.9%
HANA Micron (KOSDAQ:A067310)21.3%106.2%
UTI (KOSDAQ:A179900)33.1%134.6%
Techwing (KOSDAQ:A089030)18.7%83.6%

Click here to see the full list of 88 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

CLASSYS (KOSDAQ:A214150)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: CLASSYS Inc. is a global provider of medical aesthetics devices, with a market cap of ₩3.51 billion.

Operations: The company generates revenue primarily from its Surgical & Medical Equipment segment, amounting to ₩204.37 million.

Insider Ownership: 10.1%

Earnings Growth Forecast: 22.5% p.a.

CLASSYS, a South Korean growth company with high insider ownership, is forecast to achieve a return on equity of 28.1% in three years and is trading at 15.4% below its estimated fair value. While earnings are expected to grow significantly at 22.5% annually, they will lag behind the broader KR market's growth rate of 28.7%. Revenue is projected to increase by 19.3% per year, outpacing the market's average of 10.3%. Recent presentations at major global conferences highlight ongoing investor engagement and transparency efforts.

KOSDAQ:A214150 Earnings and Revenue Growth as at Sep 2024
KOSDAQ:A214150 Earnings and Revenue Growth as at Sep 2024

PharmaResearch (KOSDAQ:A214450)

Simply Wall St Growth Rating: ★★★★★☆

Overview: PharmaResearch Co., Ltd., along with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea and has a market cap of ₩1.91 trillion.

Operations: PharmaResearch generates its revenue primarily from its Pharmaceuticals segment, amounting to ₩296.59 billion.

Insider Ownership: 38.9%

Earnings Growth Forecast: 22.2% p.a.

PharmaResearch, a South Korean growth company with high insider ownership, is forecast to see revenue growth of 22.1% annually, outpacing the KR market's 10.3%. Earnings grew by 63.2% last year and are expected to rise significantly by 22.2% per year over the next three years, though slower than the market's 28.7%. Despite recent share price volatility, it trades at a good value—55.8% below its estimated fair value—with analysts predicting a stock price increase of 32.1%.

KOSDAQ:A214450 Earnings and Revenue Growth as at Sep 2024
KOSDAQ:A214450 Earnings and Revenue Growth as at Sep 2024

Hyosung Heavy Industries (KOSE:A298040)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Hyosung Heavy Industries Corporation manufactures and sells heavy electrical equipment in South Korea and internationally, with a market cap of ₩2.57 trillion.

Operations: The company's revenue segments include Heavy Industry at ₩3.35 trillion and Construction at ₩1.78 trillion.

Insider Ownership: 16.4%

Earnings Growth Forecast: 34.7% p.a.

Hyosung Heavy Industries, with significant insider ownership, trades at 60.7% below its estimated fair value. Despite high share price volatility, earnings grew by 117.9% last year and are forecast to rise significantly by 34.66% annually over the next three years, outpacing the KR market's 28.7%. Revenue is expected to grow at 10.7% per year, slightly above the market average of 10.3%, while analysts predict a stock price increase of 48.7%.

KOSE:A298040 Ownership Breakdown as at Sep 2024
KOSE:A298040 Ownership Breakdown as at Sep 2024

Taking Advantage

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're here to simplify it.

Discover if Hyosung Heavy Industries might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com